• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

Filtered-sunlight may effectively treat neonatal jaundice in resource-poor settings

byPuja UmaretiyaandLeah Carr, MD
May 26, 2014
in Pediatrics, Public Health
Reading Time: 17 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Filtered-sunlight phototherapy (FS-PT) was effective for the treatment of clinically significant jaundice in term and late preterm Nigerian infants on 92% of treatment days.

2. While minor temperature-related adverse outcomes occurred on 33% of treatment days, no FS-PT-treated infants experienced sunburn or dehydration.

Evidence Rating Level: 4 (Below Average)                  

Study Rundown: Phototherapy devices are effective for the treatment of unconjugated hyperbilirubinemia, but may be unavailable in resource-poor settings due to cost and unreliable electricity. This study examined the safety and efficacy of filtered-sunlight phototherapy (FS-PT) as a substitute for standard phototherapy in the treatment of clinically significant jaundice in Nigerian neonates. Effective therapy, defined as a total bilirubin rate of rise < 0.2 mg/dL/h for infants ≤ 72 hours or overall decrease in total bilirubin for infants ˃ 72 hours, occurred on 92% of treatment days. A total of 33% of infants experienced minor temperature-related adverse events, most of which were due to mild hyperthermia. None were affected by sunburn or dehydration. This study is limited by a lack of generalizability to infants cared for in colder climates and lack of a control cohort. However, this study provides support for a novel, potential alternative neonatal jaundice therapy useful in resource-poor settings with ample sunlight.

Click to read the study, published today in Pediatrics

Relevant Reading: A global need for affordable neonatal jaundice technologies

In-Depth [case-series]: A total of 227 term and late preterm infants (55.5% male, average age = 36 hours) ≤ 14 days old were enrolled in the study from December 2011 to August 2012 at the Island Maternity Hospital in Lagos, Nigeria. Clinically significant jaundice was diagnosed by transcutaneous bilirubinometer (3 mg/dL below the American Academy of Pediatrics [AAP] guidelines for initiating phototherapy). In total, the infants received 258 treatment days with 11.0% requiring 2 days of therapy and 2.6% requiring 3. The filtered-sunlight canopies used for FS-PT excluded most UV and infrared light and irradiance exceeded AAP conventional phototherapy guidelines in 97.5% of measurements. Twenty-four infants developed hypothermia (mild = 35.0-35.4°C [n = 21]; moderate < 35.0°C [n = 3]) and 61 developed hyperthermia (mild = 38.0-39.1°C [n = 60]; moderate ˃ 39.1°C [n = 1]). No infants developed sunburn or dehydration. Effective therapy was achieved on 92% of treatment days. Overall, average total bilirubin change rate was -0.06 ± 0.19 mg/dL/h.

More from this author: Delaying measles vaccination after 15 months may increase seizure risk; 65% of alcohol-related childhood vehicular deaths related to riding with drunk drivers; Prenatal SSRI use may increase risk of autism; Roadway design may decrease risk of child pedestrian collisions

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

RELATED REPORTS

Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

Topical hypericin photodynamic therapy is effective and safe in early-stage T cell lymphoma

Tags: neonatal jaundicephototherapy
Previous Post

AAP issues update on iodine deficiency and associated pollutants

Next Post

2 Minute Medicine Rewind May 19 – May 26, 2014

RelatedReports

Chronic Disease

Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

August 25, 2023
Chronic Disease

Topical hypericin photodynamic therapy is effective and safe in early-stage T cell lymphoma

July 27, 2022
#VisualAbstract: Systematic review shows a lack of high-quality evidence on the association between UV exposure and keratinocyte carcinoma development in skin of colour
StudyGraphics

#VisualAbstract: Systematic review shows a lack of high-quality evidence on the association between UV exposure and keratinocyte carcinoma development in skin of colour

March 31, 2022
Poverty, preterm birth demonstrate additive effect on cognition
Chronic Disease

Phototherapy not associated with increased risk of childhood cancer

November 3, 2021
Next Post

2 Minute Medicine Rewind May 19 – May 26, 2014

Study lends support for interferon-free treatment of hepatitis C

Prenatal screening and postnatal prophylaxis may prevent vertical Hep B transmission

Endoscopic sphincterotomy ineffective in reducing post-cholecystectomy abdominal pain [EPISOD trial]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.